文献速递慢性静脉疾病

电凝术与射频热消融治疗静脉曲张的长期结局

Long-term outcomes of electrocoagulation versus radiofrequency thermoablation for varicose veins.
PubMed 文献 · J Vasc Surg Venous Lymphat Disord · 2025-04-08

本研究对一项双盲随机临床试验中的57例患者(累计85条大隐静脉)进行长期随访,比较电凝消融(EA)与射频消融(RFA)的结局。中位随访4.8年(95%CI 4.5-5.1年)时,EA组闭塞率89.7%(n=29)vs RFA组66.7%(n=30),P=0.001;两组并发症发生率及阿伯丁静脉曲张问卷评分无显著差异。结论认为EA长期静脉闭塞率高于RFA,安全性与生活质量影响相当。

要点

  • 中位随访4.8年时,EA组大隐静脉闭塞率89.7% vs RFA组66.7%(P=0.001)。
  • 长期随访中两组并发症发生率无显著差异(P=0.127)。
  • 长期随访中两组阿伯丁静脉曲张问卷评分无显著差异(P=0.345)。

核心结论

  • EA对大隐静脉消融显示出有效性和安全性,长期随访中静脉闭塞率高于RFA。
  • 长期随访中两种方法的并发症发生及对症状和生活质量的影响相当。

研究设计与样本

  • 本研究为一项双盲随机临床试验的长期随访,研究对象为下肢静脉曲张合并大隐静脉功能不全的患者。
  • 共纳入57例患者,累计85条治疗的大隐静脉,其中EA组42条、RFA组43条。
  • 随访计划为术后1周、3个月、6个月及此后每年一次。
  • 主要结局为术后双功超声评估的大隐静脉闭塞,次要结局包括并发症发生率及阿伯丁静脉曲张问卷评分改善。

主要发现

  • 术后1周、3个月、6个月随访时,两组大隐静脉闭塞率无统计学显著差异(P值分别为0.430、0.157、0.157)。
  • 术后1周、3个月、6个月随访时,两组并发症发生率无统计学显著差异(P值分别为0.717、0.317、0.320)。
  • 术后1周、3个月、6个月随访时,两组生活质量评分改善无统计学显著差异(P值分别为0.540、0.786、0.401)。
  • 中位随访4.8年(95%CI 4.5-5.1年)时,59例手术(69.4%)数据可用,EA组闭塞率89.7%(n=29)vs RFA组66.7%(n=30),P=0.001。
  • 长期随访中两组无手术相关并发症(P=0.127),阿伯丁静脉曲张问卷评分无显著差异(P=0.345)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Thermoablation is increasingly being used as an alternative to traditional surgery for treating primary varicose veins. Electrocoagulation ablation (EA) of the great saphenous vein (GSV) has demonstrated effectiveness and safety comparable with that of radiofrequency ablation (RFA); however, its long-term outcomes have not been investigated previously. METHODS: This study involves a long-term follow-up of patients who participated in a double-blind, randomized clinical trial. Individuals with lower limb varicose veins and incompetence of GSV were randomly assigned to two treatment groups: EA and RFA. Follow-up assessments were scheduled at 1 week, 3 months, 6 months, and annually thereafter. The primary outcome measured was GSV occlusion, evaluated through postoperative duplex ultrasound examination. Secondary outcomes included the complication rate and improvements in quality of life, assessed using the Aberdeen Varicose Vein Questionnaire score. RESULTS: A total of 57 patients were included, which involved a cumulative 85 treated GSVs; 42 veins were treated with EA and 43 with RFA. At the 1-week, 3-month, and 6-month follow-ups, there were no statistically significant differences between the two groups regarding GSV occlusion rates (P = .430, P = .157, and P = .157, respectively), complication rates (P = .717, P = .317, and P = .320, respectively), or improvements in quality-of-life scores (P = .540, P = .786, and P = .401, respectively). After a median follow-up duration of 4.8 years (95% confidence interval, 4.5-5.1 years), data for 59 procedures (69.4%) were available, showing occlusion rates of 89.7% for the EA group (n = 29) and 66.7% for the RFA group (n = 30) (P = .001). There were no procedure-related complications (P = .127) and no significant differences in the Aberdeen Varicose Vein Questionnaire scores (P = .345) between the two groups analyzed. CONCLUSIONS: EA has demonstrated effectiveness and safety for ablation of the GSV, achieving a higher rate of venous occlusion compared with RFA in the long-term follow-up. Additionally, the occurrence of complications and the impact on symptoms and quality of life were comparable between the two methods during long-term follow-up.

来源:J Vasc Surg Venous Lymphat Disord,查看原文。版权归原作者所有。

引用

  1. Rossi FH, Beteli CB, Tannus MM, et al. Long-term outcomes of electrocoagulation versus radiofrequency thermoablation for varicose veins. J Vasc Surg Venous Lymphat Disord. 2025. PMID: 40209874. doi:10.1016/j.jvsv.2025.102245

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。